Carregant...

Responsiveness of Brca1 and Trp53 deficiency induced mammary preneoplasia to selective estrogen modulators versus an aromatase inhibitor in Mus musculus

An intervention study initiated at age 4 months compared the impact of tamoxifen (25mg), raloxifene (22.5mg) and letrozole (2.5mg) administered by 60-day-release-subcutaneous-pellet on mammary preneoplasia prevalence at age 6 months in conditional genetically engineered mouse models with different B...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Prev Res (Phila)
Autors principals: Alothman, Sahar J., Wang, Weisheng, Goerlitz, David S., Islam, Md, Zhong, Xiaogang, Kishore, Archana, Azhar, Redha I., Kallakury, Bhaskar V., Furth, Priscilla A.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466868/
https://ncbi.nlm.nih.gov/pubmed/28283467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-16-0268
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!